Enterovirus Surveillance During the Perinatal Period
Establishment and Application of the National Surveillance Network for Enterovirus During the Perinatal Period
1 other identifier
observational
6,500
1 country
1
Brief Summary
Neonates could be infected by non-polio enterovirus easily. Some of the neonates may develop fatal complications within one week. The objective of this study were as following: 1.To understand the composition and epidemiological characteristics of enterovirus infection in pregnant women in some areas of China; 2.To understand the transmission from mother to their neonates; 3.To understand the pathogenic spectrum composition, epidemiological characteristics and clinical characteristics of enterovirus infection in neonates; 4.To understand the genetic variation and changes of enteroviruses; 5.To establish a quality management system for maternal and neonatal enterovirus laboratory testing and monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedStudy Start
First participant enrolled
May 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2022
CompletedMay 12, 2020
May 1, 2020
1 year
May 8, 2020
May 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Detection of enterovirus
Detection of the rate of enterovirus infection and identify the genotype of enterovirus.
42 days
Secondary Outcomes (1)
Detection of antibodies of enterovirus
42 days
Study Arms (3)
General parturient
Observe the enterovirus infection in general parturients and their neonates.
Puerpera with fever
Observe the enterovirus infection in puerpera with fever and their neonates.
Febrile newborns
Observe the enterovirus infection in neonates
Interventions
Eligibility Criteria
Three population would be studied. 1. General parturient; 2. Puerpera with fever; 3, Febrile newborns.
You may qualify if:
- \. General parturient: on the first day of the third week of each month, all parturients and their newborns admitted to the hospital (day shift 8:00-18:00) within that day; 2. Puerpera with fever: all puerperas with fever (body temperature \>=37.5 degree C) and their newborns were included in summer and autumn (from May); 3. Febrile newborns: those included in summer and autumn (from May) with the following clinical characteristics: fever \>=37.5 degree C, lasting for more than one day. And sign the informed consent form with the consent of the guardian.
You may not qualify if:
- \. Pregnant women with urinary tract infection, chorioamnionitis and bacterial infection; 2. Puerpera with fever due to urinary tract infection, chorioamnionitis and bacterial infection; 3. Newborns infected with other pathogens.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bayi Children's Hospital, Seventh Medical Center, PLA general hospital
Beijing, Beijing Municipality, 100700, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2020
First Posted
May 12, 2020
Study Start
May 20, 2020
Primary Completion
May 20, 2021
Study Completion
December 25, 2022
Last Updated
May 12, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share